908 Devices Inc. (MASS)
NASDAQ: MASS · IEX Real-Time Price · USD
5.39
-0.39 (-6.75%)
Jul 19, 2024, 4:00 PM EDT - Market closed

908 Devices Revenue

908 Devices had revenue of $50.73M in the twelve months ending March 31, 2024, with 5.62% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.99M with 5.31% year-over-year growth. In the year 2023, 908 Devices had annual revenue of $50.23M with 7.21% growth.

Revenue (ttm)
$50.73M
Revenue Growth
+5.62%
P/S Ratio
3.66
Revenue / Employee
$220,578
Employees
230
Market Cap
185.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.23M3.38M7.21%
Dec 31, 202246.85M4.65M11.01%
Dec 31, 202142.21M15.31M56.93%
Dec 31, 202026.89M8.92M49.64%
Dec 31, 201917.97M-4.08M-18.51%
Dec 31, 201822.05M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 301.87M
Seres Therapeutics 126.85M
G1 Therapeutics 84.04M
EDAP TMS 65.80M
ClearPoint Neuro 26.16M
Lineage Cell Therapeutics 8.00M
Revenue Rankings